Henry Ji - Sep 2, 2022 Form 4 Insider Report for Sorrento Therapeutics, Inc. (SRNEQ)

Role
President, CEO and Chairman of the Board of Directors, Director
Signature
/s/ Henry Ji, Ph.D.
Stock symbol
SRNEQ
Transactions as of
Sep 2, 2022
Transactions value $
$0
Form type
4
Date filed
9/2/2022, 04:31 PM
Previous filing
Aug 26, 2022
Next filing
Sep 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRNEQ Common Stock Award $0 +2.5M +117.85% $0.00 4.62M Sep 2, 2022 Direct F1
holding SRNEQ Common Stock 2.27M Sep 2, 2022 See Footnote F2
holding SRNEQ Common Stock 40K Sep 2, 2022 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are represented by restricted stock units, 1/4th of which shall vest on September 2, 2023 and 1/4th of which shall vest on each anniversary thereafter.
F2 Shares are held in family trusts of which the Reporting Person is a co-trustee with his spouse.

Remarks:

President, CEO and Chairman of the Board of Directors